Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1176.00    25.00 (2.17%)
Bid:
1177.00
Ask:
1182.00
Spread: 5.00 (0.425%)
Market Cap: £815.53m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Exercise of Options, Director/PCA Dealing & TVR

28 Mar 2018 16:42

RNS Number : 3041J
CVS Group plc
28 March 2018
 

28 March 2018

CVS Group plc

("CVS" or the "Company")

Exercise of Options, Director/PDMR and PCA Dealing and Total Voting Rights

 

CVS, the UK's leading provider of veterinary services, announces that on 23 March 2018 Nick Perrin, Finance Director, together with certain other employees of the Company exercised options at 296 pence per share over an aggregate of 6,080 ordinary shares of 0.2 pence each in the Company (the "SAYE Shares") ("Ordinary Shares") in connection with the Company's December 2014 - December 2017 (January 2018 Maturity) Save As You Earn Scheme.

 

Nick Perrin, exercised options over 3,040 Ordinary Shares, subsequent to which on 27 March 2018, the Company was notified that on 23 March 2018, Mr Perrin transferred 1,590 Ordinary Shares to his wife, Julia Therese Perrin, a Person Closely Associated ("PCA") of Mr Perrin.

 

As a result, Mr Perrin's total interest in the Company, including his wife's holding, has increased to 63,040 Ordinary Shares, representing 0.09% of the total voting rights of the Company.

 

The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares took place on 28 March 2018 has been satisfied via the Company's block listing which was announced on 19 December 2017.

 

Following issue of the SAYE Shares, the Company's total issued share capital will consist of 70,314,806 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the SAYE Shares, the total number of voting rights in the Company is 70,314,806. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

 

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

 

 

Tel: 01379 644 288

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong

James Hopton

Tel: 020 7496 3000

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nick Perrin

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

 

i. Option Exercise

ii. Transfer of Ordinary Shares by a PDMR to a PCA

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

i. 296 pence

ii. Nil

i. 3,040

ii. 1,590

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

 

i. 23 March 2018

ii. 23 March 2018

f)

 

Place of the transaction

 

 

 

i. Outside of trading venue

ii. Outside of trading venue

 

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Julia Perrin

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA of Nick Perrin

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

 

i. Receipt of transfer to Ordinary Shares by a PDMR to a PCA

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

i. Nil

 

1,590

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

 

i. 23 March 2018

 

f)

 

Place of the transaction

 

 

i. Outside of trading venue

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEJPMATMBITBMP
Date   Source Headline
22nd Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20269:48 amRNSStandard form for notification of major holdings
15th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSBlock Listing Interim Review
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20264:31 pmRNSStandard form for notification of major holdings
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20269:34 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.